Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ADIL — Adial Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to ADIL Full portfolio

Position in ADIL

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$75,640
+$27,324 QoQ
Shares Held
29,547
+236.3% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 17 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADIL Over Time

Shares Held

Position Value (USD)

Derivatives in ADIL

reported options exposure · as of Jun 30, 2022
CallValue
$28,274
CallShares
34
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,151,051,707 across 436 Biotechnology names. ADIL ranks #365 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in ADIL

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,640 29,547
2025-12-31 $48,316 219,621
2025-09-30 $50,326 143,791
2024-12-31 $55,053 54,508
2024-09-30 $33,270 33,270
2024-06-30 $28,457 24,746
2022-09-30 $92,771 265,062
2022-06-30 $28,274 21,100
2021-12-31 $105,030 38,900
2021-06-30 $51,504 20,198
2021-03-31 $179,784 74,291
2020-12-31 $130,850 76,971